Outlook Therapeutics Quote - 41ON

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

Bid

Offer

Volume

0.00 Day's Range 0.00

0.00 52 Week Range 0.00

Market Cap

Previous Close

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

Shares Outstanding

260,257,517

Dividend Yield

PE Ratio

-8.18

Earnings Per Share (EPS)

-0.29

Revenue

Net Profit

-75.37M

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.outlooktherapeutics.com

Headquarters

Dover, Delaware, USA

Founded

Outlook Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the Tradegate (DE) with ticker 41ON. The last closing price for Outlook Therapeutics was -. Over the last year, Outlook Therapeutics shares have traded in a share price range of 0.00 € to 0.00 €.

Outlook Therapeutics currently has 260,257,517 shares in issue. Outlook Therapeutics has a price to earnings ratio (PE ratio) of -8.18.

Outlook Therapeutics® Announces NICE Recommendation of LYTENAVA™ (bevacizumab gamma) for the Treatment of Wet AMD

Outlook Therapeutics® Announces NICE Recommendation of LYTENAVA™ (bevacizumab gamma) for the Treatment of Wet AMD First positive reimbursement decision worldwide for LYTENAVA™; First launch...

Outlook Therapeutics® Announces UK MHRA Marketing Authorization of LYTENAVA™ (bevacizumab gamma) for the Treatment of Wet AMD

Outlook Therapeutics® Announces UK MHRA Marketing Authorization of LYTENAVA™ (bevacizumab gamma) for the Treatment of Wet AMD UK MHRA marketing authorization follows recent European...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

41ON - Frequently Asked Questions (FAQ)

What is the current Outlook Therapeutics share price?

The current share price of Outlook Therapeutics is 0.00 €

How many Outlook Therapeutics shares are in issue?

Outlook Therapeutics has 260,257,517 shares in issue

What is the 1 year trading range for Outlook Therapeutics share price?

Outlook Therapeutics has traded in the range of 0.00 € to 0.00 € during the past year

What is the PE ratio of Outlook Therapeutics?

The price to earnings ratio of Outlook Therapeutics is -8.18

What is the reporting currency for Outlook Therapeutics?

Outlook Therapeutics reports financial results in USD

What is the latest annual profit for Outlook Therapeutics?

The latest annual profit of Outlook Therapeutics is USD -75.37M

What is the registered address of Outlook Therapeutics?

The registered address for Outlook Therapeutics is 800 NORTH STATE STREET, SUITE 304, DOVER, DELAWARE, 19901

What is the Outlook Therapeutics website address?

The website address for Outlook Therapeutics is www.outlooktherapeutics.com

Which industry sector does Outlook Therapeutics operate in?

Outlook Therapeutics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
76M0Realbotix Corp	0.416 € (80.87%)	1.54M
LT1BVerifyMe Inc	2.70 € (65.64%)	43.88k
ZK7Conduit Pharmaceuticals Inc	0.129 € (60.25%)	319.72k
N79Blackbird Critical Metals Corp	0.1549 € (52.76%)	1.45k
E3O1Nexoptic Technology Corp	0.0285 € (50.00%)	3.14k
GR2Marvel Gold Limited	0.001 € (-80.00%)	95.54k
1K0IGM Biosciences Inc	1.90 € (-62.00%)	596
0PV2Moovly Media Inc	0.002 € (-55.56%)	1.5k
POTAPortofino Resources Inc	0.0028 € (-46.15%)	35k
0M4Mersana Therapeutics Inc	0.7058 € (-44.01%)	144.8k
PF8European Lithium Limited	0.0336 € (2.44%)	3M
D7GNel ASA	0.2451 € (-3.50%)	2.56M
LHADeutsche Lufthansa AG	5.656 € (0.35%)	1.9M
G7PAEnergy Transition Minerals Ltd	0.046 € (2.22%)	1.81M
RQ0DWave Quantum Inc	5.61 € (-8.12%)	1.78M